Publication | Closed Access

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Hematological MalignancyOncologyDexamethasone Versus PomalidomideMetronomic TherapyImmunologyHematologyMultiple MyelomaPharmacotherapyImmunotherapyMedicine